We serve Chemical Name:2-chloro-5-(trifluoromethyl)benzenesulfonamide CAS:779-71-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-chloro-5-(trifluoromethyl)benzenesulfonamide
CAS.NO:779-71-5
Synonyms:2-Chloro-5-trifluoromethyl-benzene;2-chloro-5-trifluoromethylbenzenesulfonamide;2-chloro-5-(trifluoromethyl)benzene-1-sulfonamide
Molecular Formula:C7H5ClF3NO2S
Molecular Weight:259.63300
HS Code:2935009090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:347.1ºC at 760 mmHg
Density:1.584g/cm3
Index of Refraction:1.51
PSA:68.54000
Exact Mass:258.96800
LogP:3.78730
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Chloro-5-trifluoromethyl-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-chloro-5-(trifluoromethyl)benzene-1-sulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloro-5-(trifluoromethyl)benzene-1-sulfonamide Use and application,2-Chloro-5-trifluoromethyl-benzene technical grade,usp/ep/jp grade.
Related News: In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine. 2-chloro-5-(trifluoromethyl)benzenesulfonamide manufacturer In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine. 2-chloro-5-(trifluoromethyl)benzenesulfonamide supplier CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion. 2-chloro-5-(trifluoromethyl)benzenesulfonamide vendor In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. 2-chloro-5-(trifluoromethyl)benzenesulfonamide factory In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.
